ADE LLC’s CVS Health CVS Stock Holding History

ADE LLC’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-301	Closed	-$21K	–	249
2020 Q4	$21K	Buy	+301	New	+$19.6K	0.02%	219

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ADE LLC's CVS Position: Q1 2021 in Review

ADE LLC sold out of CVS Health (CVS) in Q1 2021, closing a stake of 301 shares — an estimated $21K sold.

ADE LLC first reported a position in CVS in Q4 2020 and held it in 1 quarter. The position peaked at $21K in Q4 2020. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

ADE LLC reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
ADE LLC sold 301 CVS Health shares in Q1 2021, an estimated $21K.
ADE LLC first reported a position in CVS Health in Q4 2020 and held it in 1 quarter.
ADE LLC's CVS Health position peaked at $21K in Q4 2020.
2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on ADE LLC's 13F filing for Q1 2021, filed 16 Apr 2021.